Reported Holdings Of The
Sarissa Capital Management LP
Legal Name: SARISSA CAPITAL MANAGEMENT LP
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
| Security | Shares Held / Principal Amount | Market Value | Option |
|---|---|---|---|
| ALLERGAN PLC (G0177J108) | 1,042,500 | $174,545k | |
| MEDICINES CO (584688105) | 4,202,000 | $153,246k | |
| BIOGEN INC (09062X103) | 643,000 | $150,378k | |
| IRONWOOD PHARMACEUCL (46333X108) | 9,718,000 | $106,314k | |
| Innoviva Inc (45781M101) | 6,242,000 | $90,883k | |
| INTERCEPT PHARMACEUTICALS (45845P108) | 757,000 | $60,234k | |
| JAZZ PHARMA PLC (G50871105) | 196,500 | $28,013k | |
| PUMA BIOTECHNOLOGY INC (74587V107) | 1,417,000 | $18,010k | |
| MERSANA THERAPEUTICS INC (59045L106) | 3,750,000 | $15,187k | |
| CYCLERION THERAPEUTI (23255M105) | 250,000 | $2,862k | |
| REGULUS THERAPEUTICS (75915K200) | 1,851,851 | $2,314k | |
| MIRATI THERAPEUTICS INC (60468T105) | 1,000 | $103k | |
| ABBVIE INC (00287Y109) | 1,000 | $72k |